Recently, podoplanin has been shown to be a candidate marker for cancer stem cells, which is associated with cancer cell invasion and migration, as well as prognosis, in a number of types of cancer, including esophageal squamous cell carcinoma, lung squamous cell carcinoma and oral cancer (11,12,20–22). This evidence concerns the gene PDPN and esophageal squamous cell carcinoma.